Copyright Reports & Markets. All rights reserved.

Global Antihelminthics Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope of Antihelminthics
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Antihelminthics Consumption Value by Type: 2019 Versus 2023 Versus 2030
    • 1.3.2 Benzimidazoles
    • 1.3.3 Abamectin
    • 1.3.4 Salicylanilides
    • 1.3.5 Praziquantel
    • 1.3.6 Other
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Antihelminthics Consumption Value by Application: 2019 Versus 2023 Versus 2030
    • 1.4.2 Schistosomiasis
    • 1.4.3 Fasciolasis
    • 1.4.4 Filariasis
    • 1.4.5 Angiostrongylosis
    • 1.4.6 Ascariasis
    • 1.4.7 Giardiasis
    • 1.4.8 Other
  • 1.5 Global Antihelminthics Market Size & Forecast
    • 1.5.1 Global Antihelminthics Consumption Value (2019 & 2023 & 2030)
    • 1.5.2 Global Antihelminthics Sales Quantity (2019-2030)
    • 1.5.3 Global Antihelminthics Average Price (2019-2030)

2 Manufacturers Profiles

  • 2.1 Abbott
    • 2.1.1 Abbott Details
    • 2.1.2 Abbott Major Business
    • 2.1.3 Abbott Antihelminthics Product and Services
    • 2.1.4 Abbott Antihelminthics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.1.5 Abbott Recent Developments/Updates
  • 2.2 Novartis
    • 2.2.1 Novartis Details
    • 2.2.2 Novartis Major Business
    • 2.2.3 Novartis Antihelminthics Product and Services
    • 2.2.4 Novartis Antihelminthics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.2.5 Novartis Recent Developments/Updates
  • 2.3 ZEISS International
    • 2.3.1 ZEISS International Details
    • 2.3.2 ZEISS International Major Business
    • 2.3.3 ZEISS International Antihelminthics Product and Services
    • 2.3.4 ZEISS International Antihelminthics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.3.5 ZEISS International Recent Developments/Updates
  • 2.4 Johnson & Johnson
    • 2.4.1 Johnson & Johnson Details
    • 2.4.2 Johnson & Johnson Major Business
    • 2.4.3 Johnson & Johnson Antihelminthics Product and Services
    • 2.4.4 Johnson & Johnson Antihelminthics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.4.5 Johnson & Johnson Recent Developments/Updates
  • 2.5 Sanofi
    • 2.5.1 Sanofi Details
    • 2.5.2 Sanofi Major Business
    • 2.5.3 Sanofi Antihelminthics Product and Services
    • 2.5.4 Sanofi Antihelminthics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.5.5 Sanofi Recent Developments/Updates
  • 2.6 Merck & Co.
    • 2.6.1 Merck & Co. Details
    • 2.6.2 Merck & Co. Major Business
    • 2.6.3 Merck & Co. Antihelminthics Product and Services
    • 2.6.4 Merck & Co. Antihelminthics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.6.5 Merck & Co. Recent Developments/Updates
  • 2.7 GlaxoSmithKline
    • 2.7.1 GlaxoSmithKline Details
    • 2.7.2 GlaxoSmithKline Major Business
    • 2.7.3 GlaxoSmithKline Antihelminthics Product and Services
    • 2.7.4 GlaxoSmithKline Antihelminthics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.7.5 GlaxoSmithKline Recent Developments/Updates
  • 2.8 Astellas Pharma
    • 2.8.1 Astellas Pharma Details
    • 2.8.2 Astellas Pharma Major Business
    • 2.8.3 Astellas Pharma Antihelminthics Product and Services
    • 2.8.4 Astellas Pharma Antihelminthics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.8.5 Astellas Pharma Recent Developments/Updates
  • 2.9 Bayer
    • 2.9.1 Bayer Details
    • 2.9.2 Bayer Major Business
    • 2.9.3 Bayer Antihelminthics Product and Services
    • 2.9.4 Bayer Antihelminthics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.9.5 Bayer Recent Developments/Updates
  • 2.10 Mentis Pharma
    • 2.10.1 Mentis Pharma Details
    • 2.10.2 Mentis Pharma Major Business
    • 2.10.3 Mentis Pharma Antihelminthics Product and Services
    • 2.10.4 Mentis Pharma Antihelminthics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.10.5 Mentis Pharma Recent Developments/Updates
  • 2.11 Pfizer
    • 2.11.1 Pfizer Details
    • 2.11.2 Pfizer Major Business
    • 2.11.3 Pfizer Antihelminthics Product and Services
    • 2.11.4 Pfizer Antihelminthics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.11.5 Pfizer Recent Developments/Updates
  • 2.12 Sanofi
    • 2.12.1 Sanofi Details
    • 2.12.2 Sanofi Major Business
    • 2.12.3 Sanofi Antihelminthics Product and Services
    • 2.12.4 Sanofi Antihelminthics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.12.5 Sanofi Recent Developments/Updates
  • 2.13 ALLERGAN
    • 2.13.1 ALLERGAN Details
    • 2.13.2 ALLERGAN Major Business
    • 2.13.3 ALLERGAN Antihelminthics Product and Services
    • 2.13.4 ALLERGAN Antihelminthics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.13.5 ALLERGAN Recent Developments/Updates
  • 2.14 AstraZeneca
    • 2.14.1 AstraZeneca Details
    • 2.14.2 AstraZeneca Major Business
    • 2.14.3 AstraZeneca Antihelminthics Product and Services
    • 2.14.4 AstraZeneca Antihelminthics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.14.5 AstraZeneca Recent Developments/Updates

3 Competitive Environment: Antihelminthics by Manufacturer

  • 3.1 Global Antihelminthics Sales Quantity by Manufacturer (2019-2024)
  • 3.2 Global Antihelminthics Revenue by Manufacturer (2019-2024)
  • 3.3 Global Antihelminthics Average Price by Manufacturer (2019-2024)
  • 3.4 Market Share Analysis (2023)
    • 3.4.1 Producer Shipments of Antihelminthics by Manufacturer Revenue ($MM) and Market Share (%): 2023
    • 3.4.2 Top 3 Antihelminthics Manufacturer Market Share in 2023
    • 3.4.2 Top 6 Antihelminthics Manufacturer Market Share in 2023
  • 3.5 Antihelminthics Market: Overall Company Footprint Analysis
    • 3.5.1 Antihelminthics Market: Region Footprint
    • 3.5.2 Antihelminthics Market: Company Product Type Footprint
    • 3.5.3 Antihelminthics Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Antihelminthics Market Size by Region
    • 4.1.1 Global Antihelminthics Sales Quantity by Region (2019-2030)
    • 4.1.2 Global Antihelminthics Consumption Value by Region (2019-2030)
    • 4.1.3 Global Antihelminthics Average Price by Region (2019-2030)
  • 4.2 North America Antihelminthics Consumption Value (2019-2030)
  • 4.3 Europe Antihelminthics Consumption Value (2019-2030)
  • 4.4 Asia-Pacific Antihelminthics Consumption Value (2019-2030)
  • 4.5 South America Antihelminthics Consumption Value (2019-2030)
  • 4.6 Middle East and Africa Antihelminthics Consumption Value (2019-2030)

5 Market Segment by Type

  • 5.1 Global Antihelminthics Sales Quantity by Type (2019-2030)
  • 5.2 Global Antihelminthics Consumption Value by Type (2019-2030)
  • 5.3 Global Antihelminthics Average Price by Type (2019-2030)

6 Market Segment by Application

  • 6.1 Global Antihelminthics Sales Quantity by Application (2019-2030)
  • 6.2 Global Antihelminthics Consumption Value by Application (2019-2030)
  • 6.3 Global Antihelminthics Average Price by Application (2019-2030)

7 North America

  • 7.1 North America Antihelminthics Sales Quantity by Type (2019-2030)
  • 7.2 North America Antihelminthics Sales Quantity by Application (2019-2030)
  • 7.3 North America Antihelminthics Market Size by Country
    • 7.3.1 North America Antihelminthics Sales Quantity by Country (2019-2030)
    • 7.3.2 North America Antihelminthics Consumption Value by Country (2019-2030)
    • 7.3.3 United States Market Size and Forecast (2019-2030)
    • 7.3.4 Canada Market Size and Forecast (2019-2030)
    • 7.3.5 Mexico Market Size and Forecast (2019-2030)

8 Europe

  • 8.1 Europe Antihelminthics Sales Quantity by Type (2019-2030)
  • 8.2 Europe Antihelminthics Sales Quantity by Application (2019-2030)
  • 8.3 Europe Antihelminthics Market Size by Country
    • 8.3.1 Europe Antihelminthics Sales Quantity by Country (2019-2030)
    • 8.3.2 Europe Antihelminthics Consumption Value by Country (2019-2030)
    • 8.3.3 Germany Market Size and Forecast (2019-2030)
    • 8.3.4 France Market Size and Forecast (2019-2030)
    • 8.3.5 United Kingdom Market Size and Forecast (2019-2030)
    • 8.3.6 Russia Market Size and Forecast (2019-2030)
    • 8.3.7 Italy Market Size and Forecast (2019-2030)

9 Asia-Pacific

  • 9.1 Asia-Pacific Antihelminthics Sales Quantity by Type (2019-2030)
  • 9.2 Asia-Pacific Antihelminthics Sales Quantity by Application (2019-2030)
  • 9.3 Asia-Pacific Antihelminthics Market Size by Region
    • 9.3.1 Asia-Pacific Antihelminthics Sales Quantity by Region (2019-2030)
    • 9.3.2 Asia-Pacific Antihelminthics Consumption Value by Region (2019-2030)
    • 9.3.3 China Market Size and Forecast (2019-2030)
    • 9.3.4 Japan Market Size and Forecast (2019-2030)
    • 9.3.5 Korea Market Size and Forecast (2019-2030)
    • 9.3.6 India Market Size and Forecast (2019-2030)
    • 9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
    • 9.3.8 Australia Market Size and Forecast (2019-2030)

10 South America

  • 10.1 South America Antihelminthics Sales Quantity by Type (2019-2030)
  • 10.2 South America Antihelminthics Sales Quantity by Application (2019-2030)
  • 10.3 South America Antihelminthics Market Size by Country
    • 10.3.1 South America Antihelminthics Sales Quantity by Country (2019-2030)
    • 10.3.2 South America Antihelminthics Consumption Value by Country (2019-2030)
    • 10.3.3 Brazil Market Size and Forecast (2019-2030)
    • 10.3.4 Argentina Market Size and Forecast (2019-2030)

11 Middle East & Africa

  • 11.1 Middle East & Africa Antihelminthics Sales Quantity by Type (2019-2030)
  • 11.2 Middle East & Africa Antihelminthics Sales Quantity by Application (2019-2030)
  • 11.3 Middle East & Africa Antihelminthics Market Size by Country
    • 11.3.1 Middle East & Africa Antihelminthics Sales Quantity by Country (2019-2030)
    • 11.3.2 Middle East & Africa Antihelminthics Consumption Value by Country (2019-2030)
    • 11.3.3 Turkey Market Size and Forecast (2019-2030)
    • 11.3.4 Egypt Market Size and Forecast (2019-2030)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
    • 11.3.6 South Africa Market Size and Forecast (2019-2030)

12 Market Dynamics

  • 12.1 Antihelminthics Market Drivers
  • 12.2 Antihelminthics Market Restraints
  • 12.3 Antihelminthics Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Antihelminthics and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Antihelminthics
  • 13.3 Antihelminthics Production Process
  • 13.4 Antihelminthics Industrial Chain

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Antihelminthics Typical Distributors
  • 14.3 Antihelminthics Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Antihelminthics market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
    Anthelmintics or antihelminthics are a group of antiparasitic drugs that expel parasitic worms (helminths) and other internal parasites from the body by either stunning or killing them and without causing significant damage to the host.
    The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
    The Global Info Research report includes an overview of the development of the Antihelminthics industry chain, the market status of Schistosomiasis (Benzimidazoles, Abamectin), Fasciolasis (Benzimidazoles, Abamectin), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Antihelminthics.
    Regionally, the report analyzes the Antihelminthics markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Antihelminthics market, with robust domestic demand, supportive policies, and a strong manufacturing base.
    Key Features:
    The report presents comprehensive understanding of the Antihelminthics market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Antihelminthics industry.
    The report involves analyzing the market at a macro level:
    Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Benzimidazoles, Abamectin).
    Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Antihelminthics market.
    Regional Analysis: The report involves examining the Antihelminthics market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
    Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Antihelminthics market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
    The report also involves a more granular approach to Antihelminthics:
    Company Analysis: Report covers individual Antihelminthics manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
    Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Antihelminthics This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Schistosomiasis, Fasciolasis).
    Technology Analysis: Report covers specific technologies relevant to Antihelminthics. It assesses the current state, advancements, and potential future developments in Antihelminthics areas.
    Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Antihelminthics market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
    Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
    Market Segmentation
    Antihelminthics market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
    Market segment by Type
    Benzimidazoles
    Abamectin
    Salicylanilides
    Praziquantel
    Other
    Market segment by Application
    Schistosomiasis
    Fasciolasis
    Filariasis
    Angiostrongylosis
    Ascariasis
    Giardiasis
    Other
    Major players covered
    Abbott
    Novartis
    ZEISS International
    Johnson & Johnson
    Sanofi
    Merck & Co.
    GlaxoSmithKline
    Astellas Pharma
    Bayer
    Mentis Pharma
    Pfizer
    Sanofi
    ALLERGAN
    AstraZeneca
    Market segment by region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Antihelminthics product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Antihelminthics, with price, sales, revenue and global market share of Antihelminthics from 2019 to 2024.
    Chapter 3, the Antihelminthics competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Antihelminthics breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
    Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Antihelminthics market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
    Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Antihelminthics.
    Chapter 14 and 15, to describe Antihelminthics sales channel, distributors, customers, research findings and conclusion.

    Buy now